WDR5-IN-7 (Compound 22) is an orally bioavailable benzoxazepinone-based WD repeat domain 5 (WDR5) inhibitor. WDR5-IN-7 can be used for the research of anti-cancer[1].
Molecular Weight:
552.55
CAS Number:
[3032761-31-9]
Formula:
C28H27F3N6O3
Target:
Histone Methyltransferase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted